Skip to main content
Contact Us
Subscribe
E-Edition
86°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by NovaBay Pharmaceuticals, Inc.
< Previous
1
2
3
Next >
NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference
September 23, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals CEO Issues Letter to Stockholders
September 22, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals to Present at the Virtual Life Sciences Investor Forum
September 13, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctor’s Eczema Balm on Return QVC® Appearance
September 12, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million
September 09, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals to Hold Second Quarter 2022 Conference Call on August 11
August 04, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Targets New Market with Antimicrobial Avenova® Lid and Lash Spray for Lash Extensions
July 28, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals’ DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com
July 21, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Reports Record Avenova® Sales During Amazon’s Prime Day Event
July 15, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals’ DERMAdoctor Products to be Featured at Leading B2B Beauty Trade Show Cosmoprof North America
July 07, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Reports First Quarter 2022 Financial Results
May 12, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Expands Top-Selling DERMAdoctor Kakadu C and Calm Cool + Corrected Collections with New Anti-Aging Formulations
May 09, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12
May 05, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals CEO Issues Letter to Stockholders
April 25, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Introduces Hydrating Cleansing Oil to its DERMAdoctor Calm Cool + Corrected Product Line
April 01, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Reports 2021 Fourth Quarter and Full Year Financial Results
March 29, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Present DERMAdoctor Eczema Treatment as QVC® On-Air Guest
February 28, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Announces Changes to Its Board of Directors
January 28, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals to Donate 2.5 Million KN95 Masks
January 20, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
January 20, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms
January 10, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference
January 04, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Holds Special Meeting of Stockholders
December 21, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
DERMAdoctor’s Calm Cool + Corrected Eczema Balm Receives National Eczema Association Seal of Acceptance
December 13, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals CEO Issues Letter to Stockholders
November 18, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Reports Third Quarter 2021 Financial Results
November 11, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Closes DERMAdoctor Acquisition
November 08, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Closes $15.0 Million Private Placement
November 03, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Announces Pricing of $15.0 Million Private Placement
November 01, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
NovaBay Pharmaceuticals to Hold Conference Call and Webcast With Slide Presentation Today to Discuss Acquisition of DERMAdoctor
September 29, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Tickers
NBY
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.